JPH058170B2 - - Google Patents
Info
- Publication number
- JPH058170B2 JPH058170B2 JP21312283A JP21312283A JPH058170B2 JP H058170 B2 JPH058170 B2 JP H058170B2 JP 21312283 A JP21312283 A JP 21312283A JP 21312283 A JP21312283 A JP 21312283A JP H058170 B2 JPH058170 B2 JP H058170B2
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- beads
- capsules
- capsule
- filling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 40
- 239000002775 capsule Substances 0.000 claims description 25
- 239000011324 bead Substances 0.000 claims description 14
- 239000013078 crystal Substances 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- 239000007903 gelatin capsule Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229960000984 tocofersolan Drugs 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 229960001295 tocopherol Drugs 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 28
- 235000019154 vitamin C Nutrition 0.000 description 16
- 239000011718 vitamin C Substances 0.000 description 16
- 235000019165 vitamin E Nutrition 0.000 description 16
- 239000011709 vitamin E Substances 0.000 description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 14
- 229930003268 Vitamin C Natural products 0.000 description 14
- 229930003427 Vitamin E Natural products 0.000 description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 14
- 229940046009 vitamin E Drugs 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 7
- 239000011812 mixed powder Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000005204 segregation Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- -1 lipid peroxides Chemical class 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21312283A JPS60104012A (ja) | 1983-11-11 | 1983-11-11 | ビタミンｃｅ複合剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21312283A JPS60104012A (ja) | 1983-11-11 | 1983-11-11 | ビタミンｃｅ複合剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60104012A JPS60104012A (ja) | 1985-06-08 |
| JPH058170B2 true JPH058170B2 (enExample) | 1993-02-01 |
Family
ID=16633935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21312283A Granted JPS60104012A (ja) | 1983-11-11 | 1983-11-11 | ビタミンｃｅ複合剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60104012A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6303167B1 (en) * | 1998-11-09 | 2001-10-16 | Archer-Daniels-Midland Company | Method of producing vitamin powders |
-
1983
- 1983-11-11 JP JP21312283A patent/JPS60104012A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60104012A (ja) | 1985-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2856817B2 (ja) | 医薬組成物 | |
| KR101275660B1 (ko) | 베타-알라닌의 지속적 방출을 위한 조성물 및 방법 | |
| JPH0830006B2 (ja) | ビタミン類、食事療法用補助食品等を含むソフトゲル用エタノ−ル充填製剤 | |
| CA2363933C (en) | Capsule system | |
| CA2012492A1 (en) | Pharmaceutical formulation | |
| EP0152292A2 (en) | Acetaminophen gelatin capsules | |
| JPH0816051B2 (ja) | 徐放性坐剤 | |
| JPS6024767B2 (ja) | 腸溶性硬カプセル剤 | |
| JPH058170B2 (enExample) | ||
| JPS6345366B2 (enExample) | ||
| US5626872A (en) | Pharmaceutical soft capsules containing lysine clonixinate and a process for their preparation | |
| JPH0425252B2 (enExample) | ||
| JP4899304B2 (ja) | 塩酸アンブロキソール含有内服用固形製剤 | |
| ES2249777T3 (es) | Composicion farmaceutica estable a base de acido acetilsaliciclico y tocoferol. | |
| JPH0233012B2 (enExample) | ||
| IE62426B1 (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
| JPH058171B2 (enExample) | ||
| JPH0420891B2 (enExample) | ||
| JPS631923B2 (enExample) | ||
| JPS6237602B2 (enExample) | ||
| IE930446A1 (en) | Pharmaceutical soft capsules containing lysine clonixinate¹and a process for their preparation | |
| JP2008150297A (ja) | 固形製剤 | |
| JPS61200909A (ja) | 経口投与持続性カプセル剤 | |
| JPS61267552A (ja) | プロスタグランジンｅ類および／またはそれらの１５ｒ体の安定な製剤の製造方法 | |
| JPH0995442A (ja) | テプレノン製剤 |